Showing results (161-170 of 224) with videos related to
Sort By:
Pageof 23
Journal of Cancer Research and Clinical Oncology|March 24, 2012
Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapyYuki Kojima, Kenji Hashimoto, Masashi Ando, et al.Journal of Surgical Oncology|January 21, 2010
Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapyKan Yonemori, Koji Tsuta, Chikako Shimizu, et al.Cancer Science|June 19, 2012
Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cellsMayu Yunokawa, Fumiaki Koizumi, Yuka Kitamura, et al.Journal of Proteome Research|January 15, 2009
Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MSKazuko Matsumoto, Chikako Shimizu, Tokuzo Arao, et al.The Oncologist|March 16, 2016
Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying AgentsRyota Tanaka, Kan Yonemori, Akihiro Hirakawa, et al.Anti-Cancer Drugs|November 28, 2017
A case of heavily pretreated metastatic cardiac angiosarcoma treated successfully using eribulinChiaki Inagaki, Tatsunori Shimoi, Hitomi Okuma, et al.Medical Oncology (Northwood, London, England)|November 19, 2008
Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapyKan Yonemori, Koji Tsuta, Chikako Shimizu, et al.World Journal of Surgery|October 28, 2008
Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancerTadahiko Shien, Sadako Akashi-Tanaka, Kunihisa Miyakawa, et al.Breast (Edinburgh, Scotland)|May 5, 2009
21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patientsSadako Akashi-Tanaka, Chikako Shimizu, Masashi Ando, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2010
Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapyTakahiro Hasebe, Nobuko Tamura, Motoki Iwasaki, et al.Pageof 23